In the specialized field of immunology and cellular biology research, the NLVPMVATV peptide occupies a significant position. As someone who has spent considerable time exploring laboratory reagents and their specific applications, I have found that understanding the precise nature of these molecular tools is essential for any rigorous investigative work.
Defining the NLVPMVATV Peptide
The NLVPMVATV peptide is a well-characterized, linear peptidic epitope derived from the 65 kDa phosphoprotein (pp65) of the human cytomegalovirus (HCMV). Specifically, this sequence corresponds to the amino acid range 495-503. In the context of molecular biology, it is widely recognized as a dominant epitope presented by the HLA-A*02:01 allele, which is a key component of the major histocompatibility complex (MHC) Class I system.
When sourcing this material, researchers often encounter the HCMV pp65 (495-503) peptide in various forms, ranging from lyophilized powder to complexed reagents. The molecular mass of this specific antigen is approximately 943.2 Da, a detail that is critical when calculating molar concentrations for *in vitro* stimulation assays.
Practical Applications and Research Insights
My experience with high-purity reagents has shown that the quality of the peptide is paramount to achieving reproducible data. Whether utilizing synthetic native peptide (NLVPMVATV) for surface loading on antigen-presenting cells or employing Peptide-loaded MHC MACSimers, the precision of the sequence synthesis determines the reliability of the output.
For those focusing on T-cell receptor (TCR) interaction studies, the NLVPMVATV peptide acts as a standardized tool. Researchers often use this single peptide (NLVPMVATV) to stimulate CD8+ T-cells to observe specific immune recognition patterns. It is fascinating to note that this specific sequence is thought to be the dominant peptide that is presented in all HLA–A*0201 individuals, making it a "gold standard" for immune monitoring and assay development.
Advanced Experimental Tools
In the laboratory, we frequently look for more sophisticated delivery or detection methods. For instance, the Plasmid PresentER-NLVPMVATV (GFP) has become a valuable asset for those looking to NLVPMVATV is a linear peptidic epitope (epitope ID. 44920. ) studied as part of 65 kDa phosphoprotein (UniProt:Q6SW59) from Human herpesvirus 5 (Human express the e HLA-A*02:01 CMV pp65 Tetramer -NLVPMVATV (50 tests) pitope within a cellular environment. Additionally, w NLVPMVATV CMV pp65 (495 - 503) hen looking for Antigen Peptide CMV pp65 - HLA- Comparison of Cytomegalovirus-Specific Immune Cell A*0201 (NLVPMVATV), one must ensure the product meets strict purity standards—typically >97% as verified by HPLC—to avoid non-specific background interference in cellular assays.
For those working with larger experimental designs, there The CMV pp65 495-503 peptide (NLVPMVATV) is one of the most widely studied epitopes derived from the human cytomegalovirus (HCMV) pp65 protein. are various peptides available in pools, but for targeted studies, the isolated Peptidfragment (NLVPMVATV) remains the most reliable for isolating the specific response o Sep 13, 2021 — Single peptide (NLVPMVATV) for stimulation of human CMV-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC f HLA-A*0201-restricted T-cells.
Final Thoughts on Quality and Sourcing
When evaluating different suppliers, I prioritize companies that provide comprehensive documentation, such as Certificates of Analysis (CoA) and detailed mass spectrometry data. Given that this is a highly specific tool, the consistency of the NLVPMVATV sequence is non-negotiable. Whether you are conducting epitope mapping or assessing the binding affinity of novel TCR-like antibodies, utilizing a high-grade NLVPMVATV peptide ensures that yo Peptidfragment (NLVPMVATV) zur Stimulation von humanen CMV spezifischen CD8+ T-Zellen. Die Peptidsequenz entspricht der vom MHC class I HLA-A*0201 Allel ur experimental variables remain controlled.
By focusing on these specific, verifiable molecular entities, researchers can continue to advance our collective understanding of immune recognition mechanisms without relying on anecdotal or unverified materials. Always ensure that the reagents used are validated for their intended research purpose to maintain the integrity of your laboratory investigations.